Login Register Cart 0
Generic placeholder image

Current Pediatric Reviews

Editor-in-Chief

ISSN (Print): 1573-3963
ISSN (Online): 1875-6336

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Abstract

Background & Aim of the Work: β-Thalassemia (βT) is highly prevalent in some countries like Egypt. Accurate data about actual disease prevalence and heavily prevalent geographic locations are essential to help in early detection and in setting up effective preventive programs. We aim for screening βT carriers among Egyptian high school students in the Delta region.

Subjects and Methods: A cross-sectional multicenter study was carried out on 4320 randomly selected students from four governorates of the Nile Delta region, Egypt. All patients were to be tested for their complete blood count. Those with microcytic hypochromic anemia not caused by iron deficiency were tested for βT carrier status using high-performance liquid chromatography.

Results: The total prevalence of βT carrier rate was 6.13%. The highest prevalence was detected in Al-Sharkia Governorate, reaching 7.89%, followed by 6.90% in Al-Gharbia Governorate. Al- Dakahilia and Al-Menoufia showed lower rates of 4.86% and 3.73%, respectively.

Conclusion: Despite the premarital national screening program for βT in Egypt, the carrier rate is still high. More effort should be done into the proper implementation of national prevention programs.

Keywords: β-thalassemia, carrier, screening, school children, Egypt, national prevention programs.

« Previous Next »
[1]
Yang Z, Zhou W, Cui Q, Qiu L, Han B. Gene spectrum analysis of thalassemia for people residing in northern China. BMC Med Genet 2019; 20(1): 86.
[http://dx.doi.org/10.1186/s12881-019-0818-7] [PMID: 31113390]
[2]
Ullah Z, Khattak AA, Ali SA, et al. Evaluation of five discriminating indexes to distinguish beta-thalassemia trait from iron deficiency anaemia. J Pak Med Assoc 2016; 66(12): 1627-31.
[PMID: 28179703]
[3]
Rakhmilla L, Susanah S, Rohmawaty E, Effendi S. Effectiveness of an educational intervention in providing knowledge about the prevention of thalassemia: An effort to reduce new thalassemia cases. Asian J Epidemiol 2018; 11: 59-64.
[http://dx.doi.org/10.3923/aje.2018.59.64]
[4]
Jameel T, Baig M, Ahmed I, Hussain MB, Alkhamaly MBD. Differentiation of beta thalassemia trait from iron deficiency anemia by hematological indices. Pak J Med Sci 2017; 33(3): 665-9.
[http://dx.doi.org/10.12669/pjms.333.12098] [PMID: 28811791]
[5]
Pessar SA. Evaluation of twenty-four discriminant indices for differentiating beta-thalassemia trait from iron deficiency anemia in egyptians. Iran J Ped Hematol Oncol 2019; 9(3): 135-46.
[6]
El-Beshlawy A, El-Shekha A, Momtaz M, et al. Prenatal diagnosis for thalassaemia in Egypt: What changed parents’ attitude? Prenat Diagn 2012; 32(8): 777-82.
[http://dx.doi.org/10.1002/pd.3901] [PMID: 22693141]
[7]
Khalid N, Noreen K, Qureshi F, Mahesar M. Knowledge of thalassemia and consanguinity: A multicenter hospital based retrospective cohort study from metropolitan city of Karachi, Pakistan. Prof Med J 2019; 26(9): 1580-6.
[http://dx.doi.org/10.29309/TPMJ/2019.26.09.168]
[8]
El-Kady HF, Shalotout KH, El-Shourbagy MN, Al-Sodany YM. Characterization of habitats in the northwestern part of Nile Delta. The International Conference on Biological Sciences (ICBS). 2000; pp. 144-57.
[9]
National circumstances Egypt second national communication on climate change. Cairo: EEAA 2010; pp. 1-137.
[10]
Van Vranken M. Evaluation of microcytosis. Am Fam Phys 2010; 82(9): 1117-22.
[PMID: 21121557]
[11]
Zeinalian M, Nobari RF, Moafi A, Salehi M, Hashemzadeh-Chaleshtori M. Two decades of pre-marital screening for beta-thalassemia in central Iran. J Community Genet 2013; 4(4): 517-22.
[http://dx.doi.org/10.1007/s12687-013-0142-4] [PMID: 23467976]
[12]
CDC Assessing the iron status of populations: including literature reviews Report of a Joint World Health Organization/Centers for Disease Control and Prevention Technical Consultation on the assessment of iron status at the population level. (2nd ed.), Geneva, Switzerland: WHO/CDC 2007.
[13]
Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis 2010; 5: 11.
[http://dx.doi.org/10.1186/1750-1172-5-11] [PMID: 20492708]
[14]
Memish ZA, Owaidah TM, Saeedi MY. Marked regional variations in the prevalence of sickle cell disease and β-thalassemia in Saudi Arabia: Findings from the premarital screening and genetic counseling program. J Epidemiol Glob Health 2011; 1(1): 61-8.
[http://dx.doi.org/10.1016/j.jegh.2011.06.002] [PMID: 23856375]
[15]
Alswaidi FM, O’Brien SJ. Premarital screening programmes for haemoglobinopathies, HIV and hepatitis viruses: Review and factors affecting their success. J Med Screen 2009; 16(1): 22-8.
[http://dx.doi.org/10.1258/jms.2008.008029] [PMID: 19349527]
[16]
Fletcher JC, Berg K, Tranøy KE. Ethical aspects of medical genetics. A proposal for guidelines in genetic counseling, prenatal diagnosis and screening. Clin Genet 1985; 27(2): 199-205.
[http://dx.doi.org/10.1111/j.1399-0004.1985.tb00212.x] [PMID: 3978857]
[17]
El-Beshlawy A, Kaddah N, Moustafa A, Mouktar G, Youssry I. Screening for beta-thalassaemia carriers in Egypt: Significance of the osmotic fragility test. East Mediterr Health J 2007; 13(4): 780-6.
[PMID: 17955759]
[18]
Belhoul KM, Abdulrahman M, Alraei RF. Hemoglobinopathy carrier prevalence in the United Arab Emirates: First analysis of the Dubai Health Authority premarital screening program results. Hemoglobin 2013; 37(4): 359-68.
[http://dx.doi.org/10.3109/03630269.2013.791627] [PMID: 23647352]
[19]
Habibzadeh F. Thalassaemia in the Middle East Lancet.Middle East Ed. 2012; p. 379.
[20]
Al-Gazali L, Hamamy H, Al-Arrayad S. Genetic disorders in the Arab world. BMJ 2006; 333(7573): 831-4.
[http://dx.doi.org/10.1136/bmj.38982.704931.AE] [PMID: 17053236]
[21]
Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harb Perspect Med 2013; 3(2): a011775.
[http://dx.doi.org/10.1101/cshperspect.a011775] [PMID: 23378598]
[22]
Al-Farsi OA, Al-Farsi YM, Gupta I, Ouhtit A, Al-Farsi KS, Al-Adawi S. A study on knowledge, attitude, and practice towards premarital carrier screening among adults attending primary healthcare centers in a region in Oman. BMC Public Health 2014; 14: 380.
[http://dx.doi.org/10.1186/1471-2458-14-380] [PMID: 24742222]
[23]
Cao A, Rosatelli MC, Galanello R. Control of beta-thalassaemia by carrier screening, genetic counselling and prenatal diagnosis: The Sardinian experience. Ciba Found Symp 1996; 197: 137-51.
[PMID: 8827372]
[24]
Alhamdan NA, Almazrou YY, Alswaidi FM, Choudhry AJ. Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med 2007; 9(6): 372-7.
[http://dx.doi.org/10.1097/GIM.0b013e318065a9e8] [PMID: 17575503]
[25]
Angastiniotis MA, Hadjiminas MG. Prevention of thalassaemia in Cyprus. Lancet 1981; 1(8216): 369-71.
[http://dx.doi.org/10.1016/S0140-6736(81)91682-2] [PMID: 6109998]
[26]
Khorasani G, Kosaryan M, Vahidshahi K, Shakeri S, Nasehi MM. Results of the national program for prevention of beta-thalassemia major in the Iranian Province of Mazandaran. Hemoglobin 2008; 32(3): 263-71.
[http://dx.doi.org/10.1080/03630260802004269] [PMID: 18473242]
[27]
Tarazi I, Al Najjar E, Lulu N, Sirdah M. Obligatory premarital tests for beta-thalassaemia in the Gaza Strip: Evaluation and recommendations. Int J Lab Hematol 2007; 29(2): 111-8.
[http://dx.doi.org/10.1111/j.1751-553X.2006.00836.x] [PMID: 17474883]

Rights & Permissions Print Cite
Article Metrics
1
© 2024 Bentham Science Publishers | Privacy Policy